117 related articles for article (PubMed ID: 9849480)
1. Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years.
Bower M; Rustin GJ; Newlands ES; Holden L; Short D; Foskett M; Bagshawe KD
Eur J Cancer; 1998 Jul; 34(8):1204-7. PubMed ID: 9849480
[TBL] [Abstract][Full Text] [Related]
2. Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause.
Savage P; Cooke R; O'Nions J; Krell J; Kwan A; Camarata M; Dancy G; Short D; Seckl MJ; Swerdlow A
J Clin Oncol; 2015 Feb; 33(5):472-8. PubMed ID: 25547507
[TBL] [Abstract][Full Text] [Related]
3. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
4. Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors.
Rustin GJ; Newlands ES; Lutz JM; Holden L; Bagshawe KD; Hiscox JG; Foskett M; Fuller S; Short D
J Clin Oncol; 1996 Oct; 14(10):2769-73. PubMed ID: 8874338
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy after chemotherapy for gestational trophoblastic disease.
Ayhan A; Ergeneli MH; Yüce K; Yapar EG; Kişnişçi AH
J Reprod Med; 1990 May; 35(5):522-4. PubMed ID: 2161928
[TBL] [Abstract][Full Text] [Related]
6. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy.
Roberts JP; Lurain JR
Am J Obstet Gynecol; 1996 Jun; 174(6):1917-23; discussion 1923-4. PubMed ID: 8678159
[TBL] [Abstract][Full Text] [Related]
7. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
8. The management of high-risk gestational trophoblastic tumours (GTT).
Newlands ES; Bower M; Holden L; Short D; Brock C; Rustin GJ; Begent RH; Bagshawe KD
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S65-70. PubMed ID: 9833617
[TBL] [Abstract][Full Text] [Related]
9. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.
Bower M; Newlands ES; Holden L; Short D; Brock C; Rustin GJ; Begent RH; Bagshawe KD
J Clin Oncol; 1997 Jul; 15(7):2636-43. PubMed ID: 9215835
[TBL] [Abstract][Full Text] [Related]
10. Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group.
Cioffi R; Bergamini A; Gadducci A; Cormio G; Giorgione V; Petrone M; Rabaiotti E; Pella F; Candiani M; Mangili G
Int J Gynecol Cancer; 2018 Feb; 28(2):332-337. PubMed ID: 29324534
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours.
Rustin GJ; Booth M; Dent J; Salt S; Rustin F; Bagshawe KD
Br Med J (Clin Res Ed); 1984 Jan; 288(6411):103-6. PubMed ID: 6318876
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911
[TBL] [Abstract][Full Text] [Related]
13. Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate--folinic acid.
Smith EB; Weed JC; Tyrey L; Hammond CB
Am J Obstet Gynecol; 1982 Sep; 144(1):88-92. PubMed ID: 6287843
[TBL] [Abstract][Full Text] [Related]
14. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
[TBL] [Abstract][Full Text] [Related]
15. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
Soto-Wright V; Goldstein DP; Bernstein MR; Berkowitz RS
Gynecol Oncol; 1997 Jan; 64(1):156-9. PubMed ID: 8995566
[TBL] [Abstract][Full Text] [Related]
16. Management of resistant gestational trophoblastic tumors.
Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
[TBL] [Abstract][Full Text] [Related]
17. Management of low-risk metastatic gestational trophoblastic tumors.
DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein MR
J Reprod Med; 1991 Jan; 36(1):36-9. PubMed ID: 1848898
[TBL] [Abstract][Full Text] [Related]
18. No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors.
Rustin GJ; Rustin F; Dent J; Booth M; Salt S; Bagshawe KD
N Engl J Med; 1983 Mar; 308(9):473-6. PubMed ID: 6296679
[TBL] [Abstract][Full Text] [Related]
19. A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease.
Hartenbach EM; Saltzman AK; Carter JR; Twiggs LB
Gynecol Oncol; 1995 Jan; 56(1):105-8. PubMed ID: 7529741
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcome of patients conceiving within one year after chemotherapy for gestational trophoblastic tumor: a clinical report of 22 cases.
Zhu L; Song H; Yang X; Xiang Y
Chin Med J (Engl); 1998 Nov; 111(11):1004-6. PubMed ID: 11189204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
